Product Recalls in West Virginia

Product recalls affecting West Virginia — including food, drugs, consumer products, medical devices, and vehicles distributed to West Virginia. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,521 recalls have been distributed to West Virginia in the last 12 months.

48,376 total recalls
2,521 in last 12 months

Showing 94819500 of 48,376 recalls

DrugMarch 15, 2023· Baxter Healthcare Corporation

Recalled Item: Dianeal PD-2 Peritonial Dialysis Solution with 1.5% Dextrose Recalled by...

The Issue: Lack of Assurance of Sterility: Potential presence of leaks originating from...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 15, 2023· Baxter Healthcare Corporation

Recalled Item: Dianeal Low Calcium (2.5 mEq/L) Peritonial Dialysis Solution with 1.5%...

The Issue: Lack of Assurance of Sterility: Potential presence of leaks originating from...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
Medical DeviceMarch 15, 2023· Beckman Coulter, Inc.

Recalled Item: Beckman Coulter Access Free T3 Recalled by Beckman Coulter, Inc. Due to The...

The Issue: The reagent lot produces elevated results (approximately >30%) in some...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
DrugMarch 14, 2023· Hetero USA Inc

Recalled Item: Pantoprazole Sodium Delayed Release Tablets USP 40mg Recalled by Hetero USA...

The Issue: CGMP Deviations: Discoloration

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2023· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate 150mg Capsules Recalled by Ascend Laboratories, LLC Due...

The Issue: CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2023· Ascend Laboratories, LLC

Recalled Item: Dabigatran Etexilate Capsules Recalled by Ascend Laboratories, LLC Due to...

The Issue: CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
Medical DeviceMarch 14, 2023· Advanced Research Medical, LLC

Recalled Item: ADVANCED RESEARCH MEDICAL Lumbar Interbody Fusion System (OLLIF) Recalled by...

The Issue: Potential shearing of the disposable blade may occur and be contained within...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceMarch 14, 2023· Hamilton Medical AG

Recalled Item: HAMILTON-C6 Recalled by Hamilton Medical AG Due to Software error causes,...

The Issue: Software error causes, safety ventilation, in which ventilation continues in...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
DrugMarch 13, 2023· Camber Pharmaceuticals Inc.

Recalled Item: Atovaquone Oral Suspension USP Recalled by Camber Pharmaceuticals Inc. Due...

The Issue: Microbial Contamination of Non-Sterile Product: Objectionable organism,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Glimepiride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Ropinirole Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Glimepiride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Glimepiride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Ropinirole Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Finasteride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Montelukast Sodium Tablets Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund